In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
| LM_ID | Common Name | Systematic Name | Formula | Mass |
|---|---|---|---|---|
| LMFA04010008 | 4-F4-NeuroP | (E)-6-(3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010007 | 7-F4-NeuroP | (4Z,8E)-9-(3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010006 | 11-F4-NeuroP | 3-(3,5-dihydroxy-2-((1E,5Z,8Z,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid | C22H34O5 | 378.2406 |
| LMFA04010005 | 10-F4-NeuroP | (4Z,7Z,11E)-12-(3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010004 | 14-F4-NeuroP | (Z)-6-(3,5-dihydroxy-2-((1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010003 | 13-F4-NeuroP | (4Z,7Z,10Z,14E)-15-(2-ethyl-3,5-dihydroxycyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 |
| LMFA04010002 | 17-F4-NeuroP | (4Z,7Z)-9-(3,5-dihydroxy-2-((1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010001 | 20-F4-NeuroP | (4Z,7Z,10Z)-12-(3,5-dihydroxy-2-((E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010011 | ent-4-F4t-NeuroP | (R,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010012 | ent-7-epi-4-F4c-NeuroP | (R,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010013 | ent-7-epi-4-F4t-NeuroP | (R,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010014 | ent-4-F4c-NeuroP | (R,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010015 | 4-epi-4-F4c-NeuroP | (R,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010016 | 4,7-diepi-4-F4t-NeuroP | (R,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010017 | 4,7-diepi-4-F4c-NeuroP | (R,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010018 | 4-epi-4-F4t-NeuroP | (R,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010019 | ent-4-epi-4-Ft-NeuroP | (S,E)-6-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010020 | ent-4,7-diepi-4-Fc-NeuroP | (S,E)-6-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010021 | ent-4,7-diepi-4-Ft-NeuroP | (S,E)-6-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010022 | ent-4-epi-4-Fc-NeuroP | (S,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010023 | 4-F4c-NeuroP | (S,E)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010024 | 7-epi-4-F4t-NeuroP | (S,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010025 | 7-epi-4-F4c-NeuroP | (S,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010026 | 4-F4t-NeuroP | (S,E)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010027 | ent-7-F4t-NeuroP | (R,4Z,8E)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010028 | ent-10-epi-7-F4c-NeuroP | (R,4Z,8E)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010029 | ent-10-epi-7-F4t-NeuroP | (R,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010030 | ent-7-F4c-NeuroP | (R,4Z,8E)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010031 | 7-epi-7-F4c-NeuroP | (R,4Z,8E)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010032 | 7,10-diepi-7-F4t-NeuroP | (R,4Z,8E)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010033 | 7,10-diepi-7-F4c-NeuroP | (R,4Z,8E)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010034 | 7-epi-7-F4t-NeuroP | (R,4Z,8E)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010035 | ent-7-epi-4-Ft-NeuroP | (S,4Z,8E)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010036 | ent-7,10-diepi-4-Fc-NeuroP | (S,4Z,8E)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010037 | ent-7,10-diepi-4-Ft-NeuroP | (S,4Z,8E)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010038 | ent-7-epi-4-Fc-NeuroP | (S,4Z,8E)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010039 | 7-F4c-NeuroP | (S,4Z,8E)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010040 | 10-epi-7-F4t-NeuroP | (S,4Z,8E)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010041 | 10-epi-7-F4c-NeuroP | (S,4Z,8E)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010042 | 7-F4t-NeuroP | (S,4Z,8E)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010043 | ent-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010044 | ent-13-epi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010045 | ent-13-epi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010046 | ent-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010047 | 10-epi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010048 | 10,13-diepi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010049 | 10,13-diepi-10-F4c-NeuroP | (R,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010050 | 10-epi-10-F4t-NeuroP | (R,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010051 | ent-10-epi-4-Ft-NeuroP | (S,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010052 | ent-10,13-diepi-4-Fc-NeuroP | (S,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((Z)-pent-2-en-1-yl)cyclopentyl)-10-hydroxydodeca-4,7,11-trienoic acid | C22H34O5 | 378.2406 |